A multicenter study to assess efficacy, safety, and tolerability of ropeginterferon alfa-2b-njft in patients with essential thrombocythemia in the US and Canada: EXCEED-ET trial. - Masarova L; Reeves BN; El Chaer F; Foltz L; Tashi T; Abu-Zeinah G; Lucas J; Halpern AB; Maze D; Qin A; Safah H; Lan F; et al. (Frontiers in medicine, 2025)